Make prescription drugs more affordable.

Kim Schrier · Washington · Democratic

policy impact 0.80 specificity 0.93 extraction confidence 99%

Contest this claim

Occurrences

She will continue to work to bring down the cost of prescription drugs.

Schrier commits to continuing work to lower prescription drug costs.

Issues | Representative Kim Schrier
secondary · other · model gpt-5.5

Evidence

"Rep. Schrier ... has introduced a bipartisan bill that will bring down the cost of insulin." The release says the bill "paves the way for less expensive versions of brand name insulins."

Schrier took concrete legislative action early in her House career to lower drug costs, especially insulin prices.

unresolved same_term A for effort

Rep. Schrier Introduces Bipartisan Bill To Bring Down Insulin Prices
secondary · model gpt-5.4-mini · confidence 95%

Contest this evidence item

Roll Call 420 lists H.R. 5376, the Inflation Reduction Act, on motion to concur in the Senate amendment, with the result marked Passed.

Schrier voted on the measure that became the Inflation Reduction Act, which included major prescription drug pricing reforms.

partial same_term

U.S. House of Representatives Roll Call Votes
secondary · model gpt-5.4-mini · confidence 92%

Contest this evidence item

Schrier said the bill "will bring down costs for families" and listed "Allowing Medicare to negotiate lower drug prices" and "Capping insulin costs for seniors at $35/month."

Schrier publicly claimed credit for supporting enacted reforms that directly lowered prescription drug costs for Medicare beneficiaries.

partial same_term

Rep. Schrier Votes to Bring Down Health Care and Prescription Drug Costs, Invest in Combating Climate Change
secondary · model gpt-5.4-mini · confidence 93%

Contest this evidence item

CMS states the law lowers prescription drug prices in Medicare through price negotiation, caps out-of-pocket prescription drug costs at $2,000 in 2025, and caps insulin at $35 per month for Medicare beneficiaries.

Federal implementation confirms the enacted law produced concrete prescription-drug affordability gains, though only for Medicare and selected drugs.

partial same_term

The Inflation Reduction Act Lowers Health Care Costs for Millions of Americans
secondary · model gpt-5.4-mini · confidence 97%

Contest this evidence item

Assessments

partial same_term

Kim Schrier can claim partial fulfillment. During her House term, she voted for the Inflation Reduction Act, which became law in 2022 and produced real prescription-drug affordability gains, including Medicare drug-price negotiation, a $35 monthly insulin cap for Medicare beneficiaries, and a $2,000 annual out-of-pocket cap starting in 2025. That matches the promise in a meaningful but limited way. Full delivery is too strong because the reforms were narrower than a broad promise to make prescription drugs affordable overall: they mainly targeted Medicare beneficiaries and selected drugs, and Schrier's role was supportive rather than singular. Her earlier insulin-pricing bill shows serious effort, but the strongest evidence of delivery is the enacted federal law she helped advance in the same term.

provider codex_cli · model gpt-5.4 · confidence 90%

partial same_term

Schrier supported and voted for the Inflation Reduction Act during the same term, and federal implementation produced concrete prescription-drug affordability gains, including Medicare drug price negotiation, a $35 monthly insulin cap for Medicare beneficiaries, and a $2,000 annual out-of-pocket cap beginning in 2025. However, the promise was broad, and the enacted reforms mainly applied to Medicare beneficiaries and selected drugs rather than making prescription drugs broadly affordable for all patients, so the outcome is partial rather than fully delivered.

provider codex_cli · model gpt-5.5 · confidence 94%